Spark Investment Management LLC Clovis Oncology, Inc. Transaction History

Spark Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.82 - $7.72 $66,034 - $105,764	-13,700 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$5.69 - $9.69 $435,285 - $741,285	-76,500 Reduced 84.81%	13,700 $92,000
Q1 2020 May 12, 2020	SELL	$3.77 - $11.0 $174,551 - $509,300	-46,300 Reduced 33.92%	90,200 $573,000
Q4 2019 Feb 11, 2020	SELL	$3.0 - $16.43 $1.72 Million - $9.42 Million	-573,100 Reduced 80.76%	136,500 $1.42 Million
Q3 2019 Nov 12, 2019	SELL	$3.93 - $15.35 $391,699 - $1.53 Million	-99,669 Reduced 12.32%	709,600 $2.79 Million
Q2 2019 Aug 12, 2019	BUY	$12.81 - $25.67 $1.74 Million - $3.5 Million	136,169 Added 20.23%	809,269 $12 Million
Q1 2019 May 07, 2019	BUY	$17.66 - $30.28 $4.02 Million - $6.9 Million	227,800 Added 51.16%	673,100 $16.7 Million
Q4 2018 Feb 12, 2019	BUY	$11.63 - $32.67 $4.8 Million - $13.5 Million	413,000 Added 1278.64%	445,300 $8 Million
Q3 2018 Nov 13, 2018	BUY	$29.37 - $49.48 $948,651 - $1.6 Million	32,300 New	32,300 $948,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.